Intensive treatment with high-dose atorvastatin is cost effective in the secondary prevention of coronary heart disease (CHD) in the UK

By  

Inpharma, Vol. 1, Iss. 1554, 2006-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

The future of coronary heart disease prevention

By Wald David S  

Clinical Medicine, Vol. 7, Iss. 4, 2007-08 ,pp. : 392-396

Royal College Of Physicians

Access to resources Recommend Favorite

Atorvastatin Reduces Expression of the CCR2 and MAC-1 Receptors on Monocytes, and Plasma Levels of Monocyte Chemoattractant Protein-1 and C-Reactive Protein, in Patients with Coronary Heart Disease

By Fernández-Cruz A.  

Clinical Drug Investigation, Vol. 22, Iss. 1, 2002-01 ,pp. : 1-8

Adis International

Access to resources Recommend Favorite

More support for high-dose atorvastatin in coronary artery disease

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 13, 2005-10 ,pp. : 2365-2368

Informa Healthcare

Access to resources Recommend Favorite

Coronary heart disease prevention in menopausal women

By Schneider Daniel   Hsia Judith  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 5, 2005-05 ,pp. : 695-705

Informa Healthcare

Access to resources Recommend Favorite